Nathan Buchbinder is co-founder and chief strategy officer at Proscia, a pathology AI company. He sits at the intersection of the company’s customers and products and the broader digital pathology community, overseeing strategic growth opportunities and leading Proscia’s participation in industry initiatives. Nathan has a bachelor’s degree in biomedical engineering from Johns Hopkins University and a master’s degree in biomedical innovation and development from the Georgia Institute of Technology.